Literature DB >> 26656120

Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection.

Shayla Hesse1, Frederick H Neill2, Mary K Estes3, Sreejesh Shanker4, B V Venkataram Prasad5, Jennifer Ferreira6, Robert L Atmar7.   

Abstract

The performance of an assay to detect antibodies to a norovirus nonstructural fusion protein, designated VPR and consisting of three proteins (GI.1 virus protein genome-linked [VPg], a virus protease, and an RNA-dependent RNA polymerase), was evaluated. The assay sensitivity and specificity were 74.5% and >95%, respectively, for identifying GI.1 norovirus infection among persons who received either a monovalent GI.1 norovirus virus-like particle (VLP) vaccine or placebo by the intranasal route followed by an oral live GI.1 norovirus challenge.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26656120      PMCID: PMC4744919          DOI: 10.1128/CVI.00595-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  8 in total

Review 1.  Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis.

Authors:  Charles Richardson; Robert F Bargatze; Robert Goodwin; Paul M Mendelman
Journal:  Expert Rev Vaccines       Date:  2013-02       Impact factor: 5.217

2.  Determination of the 50% human infectious dose for Norwalk virus.

Authors:  Robert L Atmar; Antone R Opekun; Mark A Gilger; Mary K Estes; Sue E Crawford; Frederick H Neill; Sasirekha Ramani; Heather Hill; Jennifer Ferreira; David Y Graham
Journal:  J Infect Dis       Date:  2013-11-18       Impact factor: 5.226

3.  Norovirus vaccine against experimental human Norwalk Virus illness.

Authors:  Robert L Atmar; David I Bernstein; Clayton D Harro; Mohamed S Al-Ibrahim; Wilbur H Chen; Jennifer Ferreira; Mary K Estes; David Y Graham; Antone R Opekun; Charles Richardson; Paul M Mendelman
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

4.  Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus.

Authors:  Nadim J Ajami; Meagan A Barry; Berenice Carrillo; Zana Muhaxhiri; Frederick H Neill; B V Venkataram Prasad; Antone R Opekun; Mark A Gilger; David Y Graham; Robert L Atmar; Mary K Estes
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

Review 5.  Epidemiology of human noroviruses and updates on vaccine development.

Authors:  Sasirekha Ramani; Robert L Atmar; Mary K Estes
Journal:  Curr Opin Gastroenterol       Date:  2014-01       Impact factor: 3.287

Review 6.  Norovirus gastroenteritis.

Authors:  Roger I Glass; Umesh D Parashar; Mary K Estes
Journal:  N Engl J Med       Date:  2009-10-29       Impact factor: 91.245

7.  Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.

Authors:  David I Bernstein; Robert L Atmar; G Marshall Lyon; John J Treanor; Wilbur H Chen; Xi Jiang; Jan Vinjé; Nicole Gregoricus; Robert W Frenck; Christine L Moe; Mohamed S Al-Ibrahim; Jill Barrett; Jennifer Ferreira; Mary K Estes; David Y Graham; Robert Goodwin; Astrid Borkowski; Ralf Clemens; Paul M Mendelman
Journal:  J Infect Dis       Date:  2014-09-09       Impact factor: 5.226

8.  Norovirus disease in the United States.

Authors:  Aron J Hall; Ben A Lopman; Daniel C Payne; Manish M Patel; Paul A Gastañaduy; Jan Vinjé; Umesh D Parashar
Journal:  Emerg Infect Dis       Date:  2013-08       Impact factor: 6.883

  8 in total
  4 in total

Review 1.  Emergence of norovirus strains: A tale of two genes.

Authors:  Gabriel I Parra
Journal:  Virus Evol       Date:  2019-11-25

2.  Pairing of Parental Noroviruses with Unequal Competitiveness Provides a Clear Advantage for Emergence of Progeny Recombinants.

Authors:  Eung Seo Koo; Yong Seok Jeong
Journal:  Appl Environ Microbiol       Date:  2021-01-15       Impact factor: 4.792

3.  Profiling of humoral immune responses to norovirus in children across Europe.

Authors:  Nele Villabruna; Ray W Izquierdo-Lara; Claudia M E Schapendonk; Erwin de Bruin; Felicity Chandler; Tran Thi Nhu Thao; Brenda M Westerhuis; Janko van Beek; Louise Sigfrid; Carlo Giaquinto; Herman Goossens; Julia A Bielicki; Malte Kohns Vasconcelos; Pieter L A Fraaij; Marion P G Koopmans; Miranda de Graaf
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

Review 4.  Serological Humoral Immunity Following Natural Infection of Children with High Burden Gastrointestinal Viruses.

Authors:  Mark R Zweigart; Sylvia Becker-Dreps; Filemón Bucardo; Fredman González; Ralph S Baric; Lisa C Lindesmith
Journal:  Viruses       Date:  2021-10-09       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.